Melanotan (MT)-II HY-P0267 from MedChemExpress | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
MedChemExpress for
Melanotan (MT)-II

Description

Melanotan (MT)-II, a synthetic melanocortin receptor agonist, is an injectable peptide hormone used to promote tanning

Product Specs
ItemMelanotan (MT)-II
CompanyMedChemExpress
Price $40.00Supplier Page View Company Product Page
Catalog NumberHY-P0267
Size1 mg
ApplicationsBioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity99.97%
TypeChemical
Molecular Weight1024.18
FormulaC₅₀H₆₉N₁₅O₉
Research AreaNeurological Disease

Add to Compare List

MedChemExpress

MedChemExpress

1 Deer Park Drive, Suite F

MONMOUTH JUNCTION, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

Company Profile

Website: medchemexpress.com

(1) Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the InternetDrug testing and analysisFebruary 1, 2015Breindahl T, Evans-Brown M, Hindersson P, McVeigh J, Bellis M, Stensballe A, Kimergård A.

(2) Food intake reductions and increases in energetic responses by hindbrain leptin and melanotan II are enhanced in mice with POMC-specific PTP1B deficiencyAmerican journal of physiology. Endocrinology and metabolismSeptember 1, 2012De Jonghe BC, Hayes MR, Zimmer DJ, Kanoski SE, Grill HJ, Bence KK.

(3) Melanotan-II: Investigation of the inducer and facilitator effects on penile erection in anaesthetized ratNeuroscienceJanuary 1, 2006Giuliano F, Clément P, Droupy S, Alexandre L, Bernabé J.

(4) The potent melanocortin receptor agonist melanotan-II promotes peripheral nerve regeneration and has neuroprotective properties in the ratEuropean journal of pharmacologyFebruary 21, 2003Ter Laak MP, Brakkee JH, Adan RA, Hamers FP, Gispen WH.

(5) Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan IIInternational journal of impotence researchOctober 1, 2000Wessells H, Levine N, Hadley ME, Dorr R, Hruby V.

(6) Combination chemotherapy with a new anthracycline glycoside, aclacinomycin-A, and active drugs for malignant lymphomas in P388 mouse leukemia systemGanAugust 1, 1979Fujimoto S, Inagaki J, Horikoshi N, Ogawa M.

Be the First to Write a Review!